The generic prescription drug memantine is also available as brand-name Namenda. It comes in three forms: immediate-release tablet, oral solution, and extended-release capsule. Memantine is prescribed ...

Older adults taking memantine for Alzheimer’s disease may face a higher risk of irregular heartbeats, according to a growing body of evidence drawn from electronic health records and adverse-event ...

August 24, 2010 — The adamantine derivative, memantine, preferentially blocks excessive extrasynaptic activity of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors (NMDAR), while largely ...

Overstimulation of the N-methyl-D-aspartate (NMDA) receptor by glutamate is implicated in neurodegenerative disorders. Accordingly, we investigated memantine, an NMDA antagonist, for the treatment of ...

Alzheimer’s patients who took donepezil and memantine together had a measurably higher chance of surviving five years than ...

The drug memantine can benefit patients with moderate to severe Alzheimer's disease, according to a study reported in the April 3 New England Journal of Medicine. The use of memantine for Alzheimer's ...

The latest clinical practice guideline from the Deprescribing Guidelines for the Elderly Project, based at the Bruyère Research Institute, Ottawa, Canada, focuses on the discontinuation of ...

In a disappointing turn for Down's syndrome (DS) research, a trial to evaluate potential cognitive benefits of the drug memantine—already used as a treatment in Alzheimer's disease—showed no ...

Memantine is approved to treat moderate to severe Alzheimer's disease and other dementias. Evidence suggests that it might also be useful with bipolar disorder, depression, schizophrenia and much more ...

Clinical trials have shown the benefits of cholinesterase inhibitors for the treatment of mild-to-moderate Alzheimer's disease. It is not known whether treatment benefits continue after the ...